- Home
- TRVI vs NMRK Comparison
TRVI vs NMRK Comparison
Compare TRVI & NMRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TRVI | NMRK |
|---|---|---|
| Founded | 2011 | 1929 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.6B |
| IPO Year | 2019 | 2017 |
Fundamental Metrics
Financial Performance| Metric | TRVI | NMRK |
|---|---|---|
| Price | $17.93 | $15.72 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 5 |
| Target Price | ★ $21.55 | $18.75 |
| AVG Volume (30 Days) | ★ 2.2M | 1.4M |
| Earning Date | 05-05-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 0.76% |
| EPS Growth | 31.91 | ★ 100.00 |
| EPS | N/A | ★ 0.08 |
| Revenue | N/A | ★ $3,294,024,000.00 |
| Revenue This Year | N/A | $12.45 |
| Revenue Next Year | N/A | $8.02 |
| P/E Ratio | ★ N/A | $192.88 |
| Revenue Growth | N/A | ★ 20.29 |
| 52 Week Low | $5.78 | $12.06 |
| 52 Week High | $19.26 | $19.84 |
Technical Indicators
Market Signals| Indicator | TRVI | NMRK |
|---|---|---|
| Relative Strength Index (RSI) | 66.24 | 59.77 |
| Support Level | $10.07 | $15.34 |
| Resistance Level | N/A | $15.72 |
| Average True Range (ATR) | 1.00 | 0.48 |
| MACD | 0.18 | 0.09 |
| Stochastic Oscillator | 77.37 | 88.21 |
Price Performance
Historical ComparisonAbout TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, non-IPF interstitial lung disease, or non-IPF ILD, and refractory chronic cough, or RCC. Haduvio is an oral extended-release formulation of nalbuphine. The Company operates and manages its business as one reportable segment. Such a segment is the business of developing and commercializing the investigational therapy Haduvio.
About NMRK Newmark Group Inc.
Newmark Group Inc is a commercial real estate advisory firm. It offers services, including leasing and corporate advisory services, investment sales, commercial mortgage brokerage, appraisal and valuation, project management, and property, among others. Newmark offers a diverse array of integrated services and products designed to meet the full needs of both real estate investors/owners and occupiers. The company provides real estate strategic consulting and systems integration services to CFI's clients including many Fortune and Forbes companies, owner-occupiers, government agencies, healthcare, and higher education clients.